THAP11 and cardiomyopathy: Given the lethal phenotypes observed in our mouse models, we predict that further analyses of human RONIN and its binding partners might reveal novel mutations that could underlie a spectrum of cardiomyopathies and perhaps open the door to new therapeutic strategies (Nakamura et al., 2012).